This study demonstrated that five key genes (i.e., MYBL2, FBN2, DDX39B, TSPAN7, and GCSH) highly associated with prognosis, and immune infiltration, could promote STS via different signaling pathways. The gene discussed is FBN2; the disease is telomere syndrome.